research communications
Helicobacter pylori
of the type IV secretion system component CagX fromaState Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Science, Fuzhou 350002, People's Republic of China, bFujian Health College, Fuzhou 350101, People's Republic of China, cCCP4, Research Complex at Harwell, Rutherford Appleton Laboratory, Harwell Oxford, Didcot OX11 0FA, England, dInstitute of Integrative Biology, University of Liverpool, Liverpool L69 7ZB, England, and eThe Henry Wellcome Building for Biocatalysis, Biosciences, College of Life and Environmental Sciences, University of Exeter, Exeter EX4 4QD, England
*Correspondence e-mail: wuyk@fjirsm.ac.cn
Helicobacter pylori, a Gram-negative bacterial pathogen prevalent in the human population, is the causative agent of severe gastric diseases. An H. pylori type IV secretion (T4S) system encoded by the cytotoxin-associated gene pathogenicity island (cagPAI) is responsible for communication with host cells. As a component of the cagPAI T4S system core complex, CagX plays an important role in virulence-protein translocation into the host cells. In this work, the of the C-terminal domain of CagX (CagXct), which is a homologue of the VirB9 protein from the VirB/D4 T4S system, is presented. CagXct is only the second three-dimensional structure to be elucidated of a VirB9-like protein. Another homologue, TraO, which is encoded on the Escherichia coli conjugative plasmid pKM101, shares only 19% sequence identity with CagXct; however, there is a remarkable similarity in between these two β-sandwich protein domains. Most of the residues that are conserved between CagXct and TraO are located within the protein core and appear to be responsible for the preservation of this domain fold. The studies presented here will contribute to our understanding of different bacterial T4S systems.
Keywords: Helicobacter pylori; cytotoxin-associated gene pathogenicity island; cagPAI; type IV secretion system; CagX; crystal structure; X-ray diffraction.
PDB reference: CagX, 5h3v
1. Introduction
Helicobacter pylori is a Gram-negative bacterial pathogen which lives in the stomachs of more than half of the population of the world and causes chronic gastritis, peptic ulcers, gastric adenocarcinoma and gastric lymphoma (Blaser, 1997; Blaser & Atherton, 2004; Covacci et al., 1999; Parsonnet et al., 1994). The cytotoxin-associated gene pathogenicity island (cagPAI) contains a 40 kb foreign DNA region which is considered to be the main genetic determinant of more virulent H. pylori strains (Backert et al., 2002; Blaser & Atherton, 2004). The cagPAI carries 27 genes which encode several effector proteins and one type IV secretion (T4S) system. T4S systems are important nanomachines in Gram-negative bacteria which play important roles in various biological processes from the transfer of virulence factors into eukaryotic cells to the conjugative delivery of genetic material and the uptake or release of DNA (Cascales & Christie, 2003). The T4S system of H. pylori translocates the major effector protein CagA into gastric epithelial cells. Subsequent of intracellular CagA leads to epithelial cell elongation and disruption of tight junctions, which results in the pathogenicity of H. pylori (Backert et al., 2002; Blaser & Atherton, 2004; Odenbreit et al., 2000; Segal et al., 1997; Backert & Selbach, 2008). The T4S system has been visualized at the surface between H. pylori and gastric epithelial cells, forming a needle-like structure crossing the inner and outer membranes (Zanotti & Cendron, 2014). It has been proposed that the transmembrane core complex of the H. pylori cagPAI T4S system is formed by CagY, CagT and CagX, while the external pilus is thought to be composed of a large number of copies of CagC and CagL (Fischer, 2011; Terradot & Waksman, 2011).
As an essential component of the cagPAI T4S system core complex, CagX plays a critical role in CagA translocation into the host cell. Genetic and functional studies have indicated that the ability of H. pylori to translocate CagA into gastric cells is abrogated by inactivation of CagX (hp0528; Akopyants et al., 1998; Censini et al., 1996; Li et al., 1999; Fischer et al., 2001). The C-terminal domain of CagX has been shown to be responsible for its interaction with CagT by co-immunoprecipitation, MBP pull-down and yeast two-hybrid assays (Gopal et al., 2015).
CagX is presumed to be structurally and functionally homologous to VirB9 from the well studied VirB/D4 T4S of the plant pathogen Agrobacterium tumefaciens, although the two proteins have low sequence identity (Bayliss et al., 2007; Christie et al., 2005; Censini et al., 1996). While VirB9 forms a heterotrimer with VirB7 and VirB10 in the VirB/D4 T4S system, it is proposed that CagX associates not only with CagT and CagY, but also with CagM and Cagδ, to form a transmembrane core complex in the cagPAI T4S system (Kutter et al., 2008; Pinto-Santini & Salama, 2009).
Here, we report the expression, purification, crystallization, cagPAI T4S system folds into a β-sandwich domain containing nine β-strands. It is the first structure of a component of the transmembrane core complex of the cagPAI T4S system to be determined, and is only the second three-dimensional structure of a VirB9 homologue. The was determined by the molecular-replacement method and refined at a resolution of 1.4 Å. Comparison of the CagXct structure with that of the C-terminal domain of another VirB9 homologue, TraO, which is a part of the outer membrane complex encoded by the Escherichia coli conjugative plasmid pKM101, suggests the possible conservation of some protein–protein interactions between the pKM101 T4S system and the cagPAI T4S system.
and analysis of the C-terminal domain of the CagX protein (CagXct). This important component of the2. Materials and methods
2.1. Cloning of expression constructs and protein expression
The gene encoding the soluble fragment of Hp0528 (amino acids 396–498; CagXct) was amplified from Hp26695 genomic DNA using the primer pair FCagXct/NCagXct and subcloned into pET-32a vector via EcoRI and XhoI (Table 1). The constructed pET-32a-CagXct was transformed into E. coli BL21 (DE3) cells. Expression of CagXct was performed in LB medium containing 100 µg ml−1 ampicillin and the culture was incubated at 37°C and 220 rev min−1 until an OD600 of 0.6–0.8 was reached. 0.3 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to induce the expression of recombinant CagXct and the culture was left to shake for 12 h at 16°C and 180 rev min−1. The expression levels of CagXct were monitored by SDS–PAGE (Fig. 1).
|
2.2. Protein purification and crystallization
The cells were harvested by centrifugation (7000 rev min−1, 5 min), resuspended in a lysis buffer consisting of 50 mM Tris–HCl pH 7.0, 500 mM NaCl, 5%(v/v) glycerol, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1%(v/v) Tween 20 and then sonicated on ice (Scientz-IID). The recombinant protein was purified from the supernatant by immobilized nickel-affinity (GE Healthcare) and digested with TEV protease to remove the His tag and Trx tag (Fig. 1b). The fractions were analyzed by SDS–PAGE (Fig. 1). The purified CagXct was then concentrated to 5 mg ml−1 and applied onto a column (HiLoad 16/600 Superdex 200 75 pg; GE Healthcare) in 25 mM Tris–HCl pH 7.0, 150 mM NaCl, 5% glycerol. The trace showed that most of the CagXct eluted in a monomeric form (Fig. 2a). Fractions were assessed by 15% SDS–PAGE (Fig. 2b).
The purified CagXct was concentrated and crystallized using the sitting-drop vapour-diffusion method in 96-well Intelli-Plates (Art Robbins Instruments). The crystallization trials were set up with an ARI robot (Art Robbins Instruments) using the following screens: Crystal Screen and Crystal Screen 2 (Hampton Research) and The PEGs, JCSG and Classics Suites (Qiagen). The drops had a total volume of 1 µl and consisted of a 1:1 ratio of protein solution to precipitant. The best crystals of CagXct grew from protein solution concentrated to 70 mg ml−1 with a precipitant consisting of 27% polyethylene glycol 4000, 100 mM HEPES pH 7.5, 10% 2-propanol.
2.3. Data collection and processing
Data were collected at 100 K on the BL17U1 beamline of the Shanghai Synchrotron Radiation Facility (SSRF) at a wavelength of 0.9792 Å. The data were initially processed with HKL-2000 (Otwinowski & Minor, 1997) and the CCP4 suite (Winn et al., 2011) in the orthorhombic P212121, with unit-cell parameters a = 33.1, b = 61.6, c = 48.4 Å, α = β = γ = 90°. Owing to problems in molecular repacement (MR) and in this the data were later reprocessed as triclinic using DIALS (Waterman et al., 2016) in the xia2 pipeline (Winter et al., 2013). The overall DIALS Rmerge value decreased from 0.106 in P212121 to 0.050 in P1.
After the correct P21 with unique b = 61.6 Å, β = 90.23°, the data were reprocessed to 1.4 Å resolution in this with XDS (Kabsch, 2010) in the xia2 pipeline (Table 2).
had been established by the downstream as monoclinic
|
2.4. Structure solution and refinement
A promising MR solution was originally found in P212121 with the MrBUMP/Phaser pipeline (Keegan & Winn, 2008; McCoy et al., 2007) using the structure of chain B (TraO) of the E. coli pKM101 plasmid-encoded outer membrane complex as a search model (Chandran et al., 2009; PDB entry 3jqo; 19% sequence identity). The model, which contained one CagXct molecule per (41% solvent), was refined using REFMAC5 (Murshudov et al., 2011; Winn et al., 2001) and rebuilt using Coot (Emsley et al., 2010). Missing protein side chains were clearly visible in the electron density; however, the rebuilt structure could not be refined to an Rfree value of below 0.38. An inspection of proved to be inconclusive regarding the screw/rotation character of the crystal axes, therefore MoRDa (Vagin & Lebedev, 2015) was used to conduct MR and in every possible orthorhombic Surprisingly, high-scoring solutions were found in several space groups; however, the P212121 solution appeared to be the best since the MoRDa solutions in other space groups had higher R factors.
Intensity statistics (L-test; Padilla & Yeates, 2003) implemented in POINTLESS (Evans, 2011) suggested that the CagXct crystal belonged to a lower symmetry and was twinned. A distinct crystallographic dyad could not be determined by the processing statistics, since the merging R factors were close to 10% for each crystal axis.
To establish the true P1. The MR solution (four protein monomers) in this was found using MoRDa with PDB entry 3jqo chain B as the model. The solution had a MoRDa Q-factor of 0.71, a probability of correct solution of 99% and refined to an Rfree of 0.40 without any model rebuilding, with most of the amino-acid side chains absent. The CCP4 program Zanuda (Lebedev & Isupov, 2014) was applied to the partially refined P1 model, which had an Rfree of 0.32. The true in which the model refined to the same R values, was monoclinic P21, with unique b = 61.6 Å, β = 90.23°. The Rfree values were 0.38 or higher in all other monoclinic and orthorhombic space groups. SFCHECK (Vaguine et al., 1999) analysis of data reprocessed in P21 clearly identified a nonmerohedral (−h, −k, l) with an obliquity of 0.23° and a fraction of 0.46. Twin isotropic B-factor of the CagXct structure was performed with REFMAC. The atomic coordinates and structure factors for the CagXct structure have been deposited in the Protein Data Bank with accession code 5h3v.
the data were reprocessed in3. Results and discussion
3.1. Cloning, overexpression, purification and crystallization
The soluble fragment (residues 396–498) of CagX was successfully cloned and expressed in E. coli strain BL21 (DE3) with a His tag and a Trx tag. The tags were removed by limited proteolysis of CagXct bound to a nickel immobilized metal ion-affinity column using TEV protease. The protein was further purified by a second run of nickel immobilized metal ion-affinity and CagXct was concentrated to 70 mg ml−1 and crystallized by the vapour-diffusion method from PEG and 2-propanol.
3.2. Quality of the model
The CagXct B-factor twin in REFMAC5 at 1.4 Å resolution after the true had been established as monoclinic P21 with a β angle close to 90°, with the crystal forming a nonmerohedral twin. The quality of the electron-density maps was mostly acceptable, although some ripples were observed in the Fo − Fc map calculated using the detwinned data (Fig. 3). These ripples are likely to be caused by crystal since similar electron-density features have been reported for other twinned and order–disorder crystal structures (Lebedev et al., 2006; Rye et al., 2007). The CagXct model was refined to an R factor of 0.200 and an Rfree of 0.249 in P21 (Table 3). It contains two protein monomers with all residues built into the electron density, one PEG and two 2-propanol molecules and 129 waters. Many residue side chains were modelled with alternative conformations. The CagXct model contains no residues in the cis-conformation. Asp481 in both monomers of CagXct is a Ramachandran plot outlier, while Gly258 in the equivalent position in the TraO structure has similar main-chain torsion angles. The two monomers of CagXct comprising the can be superimposed with an r.m.s.d. of 0.38 Å over all 103 Cα atoms.
was solved by MR and subjected to isotropic
‡The Ramachandran plot analysis was performed by PROCHECK (Laskowski et al., 1993). |
3.3. Overall structure
CagXct folds into a β-sandwich domain formed by two antiparallel β-sheets containing nine β-strands (Fig. 4). β-Sheet 1 contains strands β1, β4, β5, β8 and β9 and has Richardson topology 3, 1, −2x, −1 (Richardson, 1981). β-Sheet 2 contains strands β2, β3, β6 and β7 and has topology 1, 2x, −1.
The two independent CagXct monomers do not form any oligomer between themselves or with their crystal symmetry mates, which is in line with a monomer being the main species in solution, as can be seen from the a).
trace (Fig. 23.4. Comparison of CagXct with TraO
A DALI search (Holm & Rosenström, 2010) reveals that the most similar structure to CagXct is the C-terminal domain of the VirB9 homologue TraO (TraOct) from the of the pKM101 plasmid-encoded T4S outer membrane complex (Chandran et al., 2009; PDB entry 3jqo; chain B was used as an MR model with a sequence identity of 19%). This ∼0.6 MDa complex represents a 14-fold rotational symmetry ring spanning the outer membrane which is formed by the pKM101 T4S system proteins TraOct, TraN and TraFct. An NMR structure is also available for TraO in complex with another component of the pKM101 T4S system, the VirB7-like TraN (PDB entry 3jqo; Chandran et al., 2009).
CagXct and TraOct are remarkably similar, despite their low sequence identity (Figs. 5 and 6). The region 177–270 of the TraO monomer (PDB entry 3jqo; chain B) aligns with the CagXct monomer with an r.m.s.d. of 1.4 Å over 95% of the Cα atoms. Such a high level of structural similarity may explain the success of MR structure solution using the TraO model.
To maintain structural similarity, many buried protein residues which form the protein core of TraO are conserved or substituted by residues with similar properties in CagX. Remarkably, most of these conserved residues retain the same side-chain conformation (Fig. 6). Generally, it would appear that the conservation of the overall fold/shape of the VirB9-like domain is more important for the function of this member of the T4S system than the preservation of specific individual residues that may be involved in interactions with other proteins forming the outer membrane complex of the T4S system.
3.5. Conservation of protein–protein interactions in T4S
The structure of the outer membrane complex of the T4S plasmid pKM101 (Chandran et al., 2009) provides insight into the general architecture of bacterial T4S systems. A TraOct domain in this ring structure interacts with two neighbouring TraO monomers, two TraF monomers and a single TraN monomer. Since relatively little is known about the interactions of CagX with its partners in the H. pylori T4S system, it is interesting to map the sequence/structure conservation features between TraO and CagXct onto these monomer–monomer interactions.
TraN is a long peptide which winds around TraO. It adds an additional β-strand to β-sheet 1 of TraO, which is observed in both the binary complex TraO–TraN and in the heterotrimeric outer membrane complex. Most amino-acid residues of strand β1, which runs antiparallel to TraN in TraO, are not conserved in CagX; however, the main chains of the matching residues of both these T4S proteins have the same conformation and solvent accessibility. Thus, it appears likely that the β-sheet interaction between TraO and TraN is reproduced in the Cag–CagT interface.
Interactions between different TraO monomers in the 14-fold ring of the outer membrane complex of T4S plasmid pKM101 are not extensive and the residues involved in these interactions do not appear to be conserved in CagX.
Interactions between TraO and the two monomers of TraF in this complex are more extensive; however, there is little conservation of amino-acid residues in this interface. Interestingly, one of the 2-propanol molecules binds to the main-chain N atom of the Ramachandran plot outlier Asp481 in monomer A in the CagXct structure. The main-chain N atom of the equivalent Gly258 in TraO forms a hydrogen bond to the main-chain O atom of Gly364 in TraF, with the positions of Gly364 and the 2-propanol ligand O atoms overlapping. This may suggest the preservation of another main-chain interaction in the CagX–CagY interface.
The sequence pattern `xVxVxN' (where x represents a binding residue) is shared by both structures in the β9 strand in TraO and CagXct, suggesting that the conserved nonbinding residues in this pattern may play a role in maintaining the proper distance with the β1 strand in a spatial configuration to ensure binding to a protein partner (Fig. 7). However, the binding residues are not conserved in β9; Leu484, Thr486 and Ile488 in CagXct correspond to Val261, Gly263 and Arg264 in TraO (Figs. 5 and 7). The diversity in binding residues should be determined by their different interacting protein substrates.
CagXct is only the second VirB9 homologue for which a three-dimensional structure has been elucidated. Its structure will provide additional insight into binding and translocation mechanisms of the transmembrane core complex in H. pylori and other T4S systems.
Acknowledgements
The authors thank the staff of beamline BL17U1 at Shanghai Synchrotron Radiation Facility (SSRF) for support during diffraction data collection. We thank the National Natural Science Foundation of China (Grant Nos. 31470741 and 31270790) and the National Thousand Talents Program of China for their support of this work.
References
Akopyants, N. S., Clifton, S., Kersulyte, D., Crabtree, J. E., Youree, B. E., Reece, C. A., Bukanov, N. O., Drazek, E. S., Roe, B. A. & Berg, D. E. (1998). Mol. Microbiol. 28, 37–53. CrossRef CAS PubMed Google Scholar
Backert, S., Churin, Y. & Meyer, T. F. (2002). Keio J. Med. 51, Suppl. 2, 6–14. Google Scholar
Backert, S. & Selbach, M. (2008). Cell. Microbiol. 10, 1573–1581. CrossRef PubMed CAS Google Scholar
Bayliss, R., Harris, R., Coutte, L., Monier, A., Fronzes, R., Christie, P. J., Driscoll, P. C. & Waksman, G. (2007). Proc. Natl Acad. Sci. USA, 104, 1673–1678. CrossRef PubMed CAS Google Scholar
Blaser, M. J. (1997). J. Clin. Invest. 100, 759–762. CrossRef CAS PubMed Google Scholar
Blaser, M. J. & Atherton, J. C. (2004). J. Clin. Invest. 113, 321–333. CrossRef PubMed CAS Google Scholar
Cascales, E. & Christie, P. J. (2003). Nature Rev. Microbiol. 1, 137–149. Web of Science CrossRef CAS Google Scholar
Censini, S., Lange, C., Xiang, Z., Crabtree, J. E., Ghiara, P., Borodovsky, M., Rappuoli, R. & Covacci, A. (1996). Proc. Natl Acad. Sci. USA, 93, 14648–14653. CrossRef CAS PubMed Web of Science Google Scholar
Chandran, V., Fronzes, R., Duquerroy, S., Cronin, N., Navaza, J. & Waksman, G. (2009). Nature (London), 462, 1011–1015. Web of Science CrossRef PubMed CAS Google Scholar
Christie, P. J., Atmakuri, K., Krishnamoorthy, V., Jakubowski, S. & Cascales, E. (2005). Annu. Rev. Microbiol. 59, 451–485. CrossRef PubMed CAS Google Scholar
Covacci, A., Telford, J. L., Del Giudice, G., Parsonnet, J. & Rappuoli, R. (1999). Science, 284, 1328–1333. Web of Science CrossRef PubMed CAS Google Scholar
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. Web of Science CrossRef CAS IUCr Journals Google Scholar
Evans, P. R. (2011). Acta Cryst. D67, 282–292. Web of Science CrossRef CAS IUCr Journals Google Scholar
Fischer, W. (2011). FEBS J. 278, 1203–1212. CrossRef CAS PubMed Google Scholar
Fischer, W., Püls, J., Buhrdorf, R., Gebert, B., Odenbreit, S. & Haas, R. (2001). Mol. Microbiol. 42, 1337–1348. Web of Science CrossRef PubMed CAS Google Scholar
Gopal, G. J., Pal, J., Kumar, A. & Mukhopadhyay, G. (2015). Biochem. Biophys. Res. Commun. 456, 98–103. CrossRef CAS PubMed Google Scholar
Holm, L. & Rosenström, P. (2010). Nucleic Acids Res. 38, W545–W549. Web of Science CrossRef CAS PubMed Google Scholar
Kabsch, W. (2010). Acta Cryst. D66, 125–132. Web of Science CrossRef CAS IUCr Journals Google Scholar
Keegan, R. M. & Winn, M. D. (2008). Acta Cryst. D64, 119–124. Web of Science CrossRef CAS IUCr Journals Google Scholar
Kutter, S., Buhrdorf, R., Haas, J., Schneider-Brachert, W., Haas, R. & Fischer, W. (2008). J. Bacteriol. 190, 2161–2171. Web of Science CrossRef PubMed CAS Google Scholar
Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. (1993). J. Appl. Cryst. 26, 283–291. CrossRef CAS Web of Science IUCr Journals Google Scholar
Lebedev, A. A. & Isupov, M. N. (2014). Acta Cryst. D70, 2430–2443. Web of Science CrossRef IUCr Journals Google Scholar
Lebedev, A. A., Vagin, A. A. & Murshudov, G. N. (2006). Acta Cryst. D62, 83–95. Web of Science CrossRef CAS IUCr Journals Google Scholar
Li, S. D., Kersulyte, D., Lindley, I. J., Neelam, B., Berg, D. E. & Crabtree, J. E. (1999). Infect. Immun. 67, 3893–3899. PubMed CAS Google Scholar
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. Web of Science CrossRef CAS IUCr Journals Google Scholar
McNicholas, S., Potterton, E., Wilson, K. S. & Noble, M. E. M. (2011). Acta Cryst. D67, 386–394. Web of Science CrossRef CAS IUCr Journals Google Scholar
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011). Acta Cryst. D67, 355–367. Web of Science CrossRef CAS IUCr Journals Google Scholar
Odenbreit, S., Püls, J., Sedlmaier, B., Gerland, E., Fischer, W. & Haas, R. (2000). Science, 287, 1497–1500. CrossRef PubMed CAS Google Scholar
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. CrossRef CAS PubMed Web of Science Google Scholar
Padilla, J. E. & Yeates, T. O. (2003). Acta Cryst. D59, 1124–1130. Web of Science CrossRef CAS IUCr Journals Google Scholar
Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A. B., Warnke, R. A., Jellum, E., Orentreich, N., Vogelman, J. H. & Friedman, G. D. (1994). N. Engl. J. Med. 330, 1267–1271. CrossRef CAS PubMed Google Scholar
Pinto-Santini, D. M. & Salama, N. R. (2009). J. Bacteriol. 191, 7343–7352. PubMed CAS Google Scholar
Richardson, J. S. (1981). Adv. Protein Chem. 34, 167–339. CrossRef CAS PubMed Google Scholar
Robert, X. & Gouet, P. (2014). Nucleic Acids Res. 42, W320–W324. Web of Science CrossRef CAS PubMed Google Scholar
Rye, C. A., Isupov, M. N., Lebedev, A. A. & Littlechild, J. A. (2007). Acta Cryst. D63, 926–930. Web of Science CrossRef CAS IUCr Journals Google Scholar
Segal, E. D., Lange, C., Covacci, A., Tompkins, L. S. & Falkow, S. (1997). Proc. Natl Acad. Sci. USA, 94, 7595–7599. CrossRef CAS PubMed Google Scholar
Terradot, L. & Waksman, G. (2011). FEBS J. 278, 1213–1222. CrossRef CAS PubMed Google Scholar
Vagin, A. & Lebedev, A. (2015). Acta Cryst. A71, s19. CrossRef IUCr Journals Google Scholar
Vaguine, A. A., Richelle, J. & Wodak, S. J. (1999). Acta Cryst. D55, 191–205. Web of Science CrossRef CAS IUCr Journals Google Scholar
Waterman, D. G., Winter, G., Gildea, R. J., Parkhurst, J. M., Brewster, A. S., Sauter, N. K. & Evans, G. (2016). Acta Cryst. D72, 558–575. Web of Science CrossRef IUCr Journals Google Scholar
Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242. Web of Science CrossRef CAS IUCr Journals Google Scholar
Winn, M. D., Isupov, M. N. & Murshudov, G. N. (2001). Acta Cryst. D57, 122–133. Web of Science CrossRef CAS IUCr Journals Google Scholar
Winter, G., Lobley, C. M. C. & Prince, S. M. (2013). Acta Cryst. D69, 1260–1273. Web of Science CrossRef CAS IUCr Journals Google Scholar
Zanotti, G. & Cendron, L. (2014). World J. Gastroenterol. 20, 1402–1423. CrossRef PubMed Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.